Posted by Michael Wonder on 28 Sep 2016
Medicines Australia's take on the R&D tax incentive review
28 Septemnber 2016 - Medicines Australia welcomes the release of the report commissioned by the Australian Government into the R&D Tax Incentive Programme.
The report, authored by three of Australia’s most experienced business and scientific minds has outlined some interesting and worthwhile ideas to encourage more investment in Australian research and development which deserve further exploration by the Government and affected industries.
